Arch Biopartners Inc. (ACHFF)
OTCMKTS · Delayed Price · Currency is USD
0.3520
+0.0020 (0.57%)
Apr 15, 2026, 4:00 PM EST
Arch Biopartners Market Cap
Arch Biopartners has a market cap or net worth of $23.93 million as of April 16, 2026. Its market cap has decreased by -68.67% in one year.
Market Cap
23.93M
Enterprise Value
25.85M
Revenue
115.29K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.35
Market Cap Chart
Since January 21, 2011, Arch Biopartners's market cap has decreased from 33.63M to 23.93M, a decrease of -28.83%. That is a compound annual growth rate of -2.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 23.78M | -59.79% |
| Dec 31, 2025 | 59.13M | -32.56% |
| Dec 31, 2024 | 87.67M | 25.12% |
| Dec 29, 2023 | 70.07M | -46.02% |
| Dec 30, 2022 | 129.79M | -23.83% |
| Dec 31, 2021 | 170.40M | 138.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vicapsys Life Sciences | 47.26M |
| Harvard Apparatus Regenerative Technology | 27.64M |
| Provectus Biopharmaceuticals | 23.07M |
| Anebulo Pharmaceuticals | 20.39M |
| Oncotelic Therapeutics | 16.04M |
| EOM Pharmaceuticals Holdings | 15.03M |
| HOOKIPA Pharma | 14.66M |
| Zeo ScientifiX | 13.68M |